Abstract
Non-Hodgkin’s Lymphoma (NHL) is a malignancy of the lymphoid lineage of the hematopoietic system has worldwide, especially in developed countries. Better diagnostic and recording techniques, longer life expectancy, and greater exposure to risk factors are hypotheses for this growing incidence curve. Occupational exposures to chemical, biological, and physical agents have also been associated with NHL development, but the results are still controversial. We have investigated the occupational and lifestyle case-control study design with 214 adult patients and 452 population controls. Socio-demographic, clinical, and occupational exposure data were obtained through individual interviews with a standardized questionnaire. Clinical, laboratory, and histopathological data were obtained through medical records. Risk of NHL (any subtype), B-cell lymphoma, DLBCL, Follicular lymphoma and T-cell lymphoma was elevated among the those who had ever been exposed to any solvents, hydrocarbon solvents, pesticides, meat and meat products, and sunlight and tended to increase by years of exposure. A significant upward trend with years of exposure was detected for any solvents and hydrocarbon solvents (NHL (any subtype) p-value for trend<0.001), B-cell lymphoma (p-value for trend<0.001), and T-cell lymphoma (p-value for trend<0.023), pesticides (NHL (any subtype), p for trend<0.001) and T-cell lymphoma (p for trend<0.002), meat and meat products (NHL (any subtype) (p for trend<0.001) and DLBCL (p for trend<0.001), and sunlight (B-cell lymphoma (p for trend<0.001). The results of this study agree line with other international studies, can be extrapolated to other countries that have the same socio-demographic and occupational characteristics as Brazil and support strategies for surveillance and control of work-related cancer.
Funder
Pan-American Health Organization
Brazilian National Cancer Institute
FAPERJ
CNPQ/INCA
Publisher
Public Library of Science (PLoS)
Reference46 articles.
1. New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy.;D Chihara;Expert Rev Anticancer Ther,2015
2. DeVita, Hellman, and Rosenberg’s cancer: Principles & practice of oncology.;VT DeVita;DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology.,2018
3. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001;LM Morton;Blood,2006
4. Risk factors of non-Hodgkin’s lymphoma.;Y Zhang;Expert Opin Med Diagn,2011
5. GLOBOCAN 2018: counting the toll of cancer;GLOBOCAN 2018;The Lancet. Elsevier Ltd,2018